neleidžiama
neleidžiama
Skaitmeninių teisių valdymas (DRM)
Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).
Reikalinga programinė įranga
Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)
Norint skaityti šią el. knygą asmeniniame arba Mac kompiuteryje, Jums reikalinga Adobe Digital Editions (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas Adobe Reader, kurią tikriausiai jau turite savo kompiuteryje.)
Negalite skaityti šios el. knygos naudodami Amazon Kindle.
Section 1 Drug safety-related issues
1. Introduction: Why do we need a book on drug safety in developing countries?
2. Medications safety-related terminology
3. Medications registration and marketing: safety-related issues
4. Pharmacovigilance
5. Adverse drug reactions
6. Medication errors
7. Self-medication
8. Antibiotics safety issue
9. Drug-related problems
10. Counterfeit and substandard medications
11. Medication abuse and misuse
12. Storage and disposal of medications
13. Safety of medications in special population
14. Herbal medicines safety issues
15. Medications safety resources and tools
16. Medications safety pharmacoeconomics-related issues
17. Evidence-based medications safety practice
18. Technology in medications safety
19. Medications safety research issues
20. Quality indicators for medications safety
Section 2: Drug Safety in Asia 21. Drug safety in Malaysia
22. Drug safety in Thailand
23. Drug safety in Indonesia
24. Drug safety in Pakistan
25. Drug safety in India
26. Drug safety in Nepal
27. Drug safety in Sri Lanka
28. Drug Safety in China
Section 3: Drug Safety in Middle East 29. Drug safety in Yemen
30. Drug safety in Saudi Arabia
31. Drug safety in UAE
32. Drug safety in Jordan
33. Drug safety in Lebanon
34. Drug safety in Palestine
35. Drug safety in Qatar
Section 4: Drug Safety in Africa
36. Drug safety in Sudan
37. Drug safety in Egypt
38. Drug safety in Nigeria
39. Drug safety in Mali
40. Drug safety in Burkina Faso
Section 5: Drug Safety in Latin America 41. Drug safety in Chile
Section 6: Comparisons and conclusions
42. Compare between the developing countries
43. Drug Safety in Developing Versus Developed countries